Antibody therapeutics - ImmunoQureAlternative Names: IQ 002; IQ-001; IQ-003; IQ-004; IQ-005; IQ-006
Latest Information Update: 19 Aug 2016
At a glance
- Originator ImmunoQure AG
- Class Antibodies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Autoimmune disorders; Inflammation
Most Recent Events
- 18 Jul 2016 Early research in Autoimmune disorders in Germany (Parenteral)
- 18 Jul 2016 Early research in Inflammation in Germany (Parenteral)